Pregled bibliografske jedinice broj: 813857
The Benefit and Future of Pharmacogenetics
The Benefit and Future of Pharmacogenetics // Total Intravenous Anesthesia and Target Controlled Infusions. A Comprehensive Global Anthology / Absalom, Anthony R. ; Mason, Keira P. (ur.)., 2017. str. 697-711 doi:10.1007/978-3-319-47609-4_38
CROSBI ID: 813857 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The Benefit and Future of Pharmacogenetics
Autori
Samardžić, Janko ; Švob Štrac, Dubravka ; van den Anker, Johannes N.
Vrsta, podvrsta i kategorija rada
Poglavlja u knjigama, pregledni
Knjiga
Total Intravenous Anesthesia and Target Controlled Infusions. A Comprehensive Global Anthology
Urednik/ci
Absalom, Anthony R. ; Mason, Keira P.
Izdavač
Springer
Godina
2017
Raspon stranica
697-711
ISBN
978-3-319-47607-0
Ključne riječi
pharmacogenetics ; total intravenous anesthesia ; therapeutic drug efficacy ; adverse drug reactions
Sažetak
In recent years pharmacogenetics has received major attention in many areas of medicine, giving the potential basis of precision medicine in the near future. Determination of genetic factors of prognostic value for a target drug choice and dosing regimen will improve the safe and effective use of medicines in patients of all ages. Individual differences in pharmacological responses might lead to serious clinical problems such as difficulties in reaching optimal efficacy, appearance of drug interactions and adverse drug reactions (ADRs). Based upon the current knowledge, it is clear that an early adjustment of a therapy regimen using genetic characteristics of a patient can help prevent some of these side effects. Thus, the application of pharmacogenetics might have a great potential in helping providers to reduce and prevent ADRs and to improve therapeutic drug efficacy .
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
